Source: International Congress 2019 – Quality, performance and interpretation of lung function testing



Rating:

Share or cite this content

Citations should be made in the following way:
J. Blonshine (Mason, United States of America), S. Blonshine (Mason, United States of America). DLco simulations for qualification of DLco devices globally for inhaled levodopa clinical trials.. 1133

Member's Comments

No comment yet.

Related content which might interest you: Adherence rates to 2005 ATS/ERS test performance standards for spirometry, single-breath diffusing capacity (DLco), and lung volumes in a multi-center inhaled insulin study Source: Annual Congress 2008 - Beyond spirometry: the skills behind lung function testing Year: 2008 Quality control of DL,CO instruments in global clinical trials Source: Eur Respir J 2009; 33: 828-834 Year: 2009 Reducing the variability of DLCO measurements in clinical trials Source: International Congress 2019 – Physiologic assessment of airway diseases Year: 2019 Accuracy for DLco impairment through ventilatory efficiency indices in smokers without COPD. Source: Virtual Congress 2021 – Lung function evaluation and assessment of airway diseases Year: 2021 Long-term accuracy of DLCO devices Source: Virtual Congress 2021 – Future advances in respiratory physiology Year: 2021 Impulse oscillometry parameters of COPD patients during inspiration and expiration and the effect of tiotropium inhalation therapy Source: Annual Congress 2008 - Beyond spirometry: the skills behind lung function testing Year: 2008 Closing volume predicts the FEV1 response to bronchodilators in patients with COPD Source: Virtual Congress 2020 – Advances in lung function testing Year: 2020 Does an acute FEV1 response predict long-term improvements with bronchodilators in patients with COPD? Source: Eur Respir J 2001; 18: Suppl. 33, 486s Year: 2001 DLCO biological controls in clinical practice. Source: International Congress 2019 – Quality, performance and interpretation of lung function testing Year: 2019 Metronome-paced hyperventilation, CT measurements and exercise to investigate dynamic hyperinflation contrasting tiotropium versus indacaterol treatment in moderate COPD patients Source: International Congress 2015 – Unravelling the mechanisms of symptoms and exercise limitationas in disease Year: 2015 Analysis of the post bronchodilator forced expiratory volume in one second of COPD patients clinically followed up for three years Source: Annual Congress 2013 –COPD diagnosis Year: 2013 FEV6 and FEV1/FEV6 as an alternative for FVC and FEV1/FVC in monitoring response to prednisolone treatment Source: Annual Congress 2010 - Quality measurement and improvement in lung function Year: 2010 Normal lung function and absence of bronchodilator response in children with stable, controlled asthma using inhaled corticosteroids Source: Annual Congress 2006 - New features of paediatric asthma Year: 2006 Measuring bronchodilation in COPD clinical trials Source: Eur Respir J 2004; 24: Suppl. 48, 122s Year: 2004 Usefulness of post bronchodilator FVC in the evaluation and spirometric evolution of COPD patients Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013 COPDGene intra-subject variability of DLco measurements using an ultrasound-based instrument Source: International Congress 2015 – Monitoring airway diseases with lung function tests Year: 2015 A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo Source: Eur Respir J 2006; 28: Suppl. 50, 764s Year: 2006 Assessment of lung volumes and capacities in bronchodilator reversibility changes of hyperinflation of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Rate of FEV1 decline by FEV1 percent predicted in UPLIFT® and TIOSPIR® Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 FEV6 and FEV1/FEV6 have higher association with small airway function and oxygen saturation than FVC and FEV1/FVC in patients with asthma. Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers Year: 2020